Environmental, Social And Governance Report

Overview

The report describes Ascentage Pharma's 2021 ESG performance, including 942.10 tCO 2e of total greenhouse gas emissions, 613 employees and zero work-related fatalities. It also highlights environmental goals to source 50% of consumed electricity from renewable resources by 2032 and reduce 2040 carbon emissions by 50% from peak levels. The report further describes ESG oversight by the Board of Directors and Audit Committee.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 19 May 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services